All Stories

  1. In Memoriam: Richard O. Hynes (1944–2026)
  2. SNED1 fibrillar assembly in the extracellular matrix requires fibronectin and collagen I
  3. SNED1 modulates ECM architecture and cell proliferation via LDV-binding integrins
  4. Comparative proteomic analysis of the ECM composition of the human omentum and mesentery, the main sites of ovarian cancer metastasis
  5. A guide to building the matrisome interactome: from computational predictions to experimental validation
  6. Fibronectin composition and transglutaminase 2 cross-linking cooperatively regulate ovarian cancer cell adhesion in ECM-mimetic constructs
  7. In-depth proteomic profiling of the extracellular matrix of pancreatic ductal adenocarcinomas identifies signatures correlating with lymphocyte infiltration
  8. Comparative proteomic analysis of the ECM composition of the human omentum and mesentery, the main sites of ovarian cancer metastasis
  9. MatriCom, a single-cell RNA-sequencing data mining tool to infer cell–extracellular matrix interactions
  10. Fibronectin Composition and Transglutaminase 2 Cross-linking Cooperatively Regulate Ovarian Cancer Cell Adhesion in ECM-Mimetic Constructs
  11. Time-lapse tryptic digestion: a proteomic approach to improve sequence coverage of extracellular matrix proteins
  12. The novel ECM protein SNED1 mediates cell adhesion via the RGD-binding integrins α5β1 and αvβ3
  13. MatriCom: a scRNA-Seq data mining tool to infer ECM-ECM and cell-ECM communication systems
  14. MatrixDB 2024: an increased coverage of extracellular matrix interactions, a new Network Explorer and a new web interface
  15. Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease
  16. Mechanisms of assembly and remodelling of the extracellular matrix
  17. The novel ECM protein SNED1 mediates cell adhesion via the RGD-binding integrins α5β1 and αvβ3
  18. Extracellular matrix dynamics: A key regulator of cell migration across length-scales and systems
  19. Matrisome AnalyzeR – a suite of tools to annotate and quantify ECM molecules in big datasets across organisms
  20. Desalting of Peptides to Prepare for Mass Spectrometry Analysis v2
  21. Matrisome AnalyzeR: A suite of tools to annotate and quantify ECM molecules in big datasets across organisms
  22. Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives
  23. Data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  24. Data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  25. GSEA gene sets from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  26. Ingenuity Pathway Analysis from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  27. MS data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  28. Supplementary Figures from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  29. GSEA gene sets from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  30. Marker selection from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  31. Supplementary Tables from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  32. Ingenuity Pathway Analysis from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  33. Supplementary Figures from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  34. MS data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  35. Supplementary Tables from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  36. Marker selection from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  37. Compartmental Protein Extraction to Achieve Enrichment of Extracellular Matrix (ECM) Proteins v1
  38. Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis
  39. Beyond the matrisome: New frontiers in ECM research
  40. MatrisomeDB 2.0: 2023 updates to the ECM-protein knowledge database
  41. Systematic Analysis of Actively Transcribed Core Matrisome Genes Across Tissues and Cell Phenotypes
  42. New Views of Old Proteins: Clarifying the Enigmatic Proteome
  43. Time-lapsed proteomics reveals a role for the novel protein, SNED1, in modulating ECM composition and protein folding
  44. The matrix in focus: new directions in extracellular matrix research from the 2021 ASMB hybrid meeting
  45. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy
  46. Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas
  47. Computational and experimental characterization of the novel ECM glycoprotein SNED1 and prediction of its interactome
  48. The Burden of Post-Translational Modification (PTM)—Disrupting Mutations in the Tumor Matrisome
  49. Knockout of the gene encoding the extracellular matrix protein SNED1 results in early neonatal lethality and craniofacial malformations
  50. Spatial-omics: Novel approaches to probe cell heterogeneity and extracellular matrix biology
  51. The liver matrisome – looking beyond collagens
  52. Computational and experimental characterization of the novel ECM glycoprotein SNED1 and prediction of its interactome
  53. Pan-Cancer Analysis of the Genomic Alterations and Mutations of the Matrisome
  54. Proteomic pipeline to identify age-related compositional and structural changes of the human dentin extracellular matrix
  55. Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  56. The Extracellular Matrix Goes -Omics: Resources and Tools
  57. The Matrisome of Model Organisms: From In-Silico Prediction to Big-Data Annotation
  58. In-silico definition of the Drosophila melanogaster matrisome
  59. MatrisomeDB: the ECM-protein knowledge database
  60. Exploring the extracellular matrix in health and disease using proteomics
  61. The in-silico characterization of the Caenorhabditis elegans matrisome and proposal of a novel collagen classification
  62. MatrixDB: integration of new data with a focus on glycosaminoglycan interactions
  63. Knockout of the gene encoding the extracellular matrix protein Sned1 results in craniofacial malformations and early neonatal lethality
  64. The cancer matrisome: From comprehensive characterization to biomarker discovery
  65. Extracellular matrix in lung development, homeostasis and disease
  66. The in-silico zebrafish matrisome: A new tool to study extracellular matrix gene and protein functions
  67. Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics
  68. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival
  69. Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
  70. Comprehensive proteomic characterization of stem cell-derived extracellular matrices
  71. Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression
  72. Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE
  73. The extracellular matrix: Tools and insights for the “omics” era
  74. Enrichment of Extracellular Matrix Proteins from Tissues and Digestion into Peptides for Mass Spectrometry Analysis
  75. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
  76. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters
  77. Towards definition of an ECM parts list: An advance on GO categories
  78. Abstract SY28-01: Multiple changes in tumor extracellular matrices
  79. Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells
  80. Ezrin regulates microvillus morphogenesis by promoting distinct activities of Eps8 proteins
  81. The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
  82. Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
  83. Emerging role for ERM proteins in cell adhesion and migration
  84. Abstract 2370: A novel Src/Ezrin pathway regulates local invasion and metastasis of breast
  85. Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity
  86. Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia
  87. Spatial recruitment and activation of the Fes kinase by ezrin promotes HGF‐induced cell scattering